Biologics Facility Design & Pharmaceutical Regulatory Aspects - 2017
This course explores some of the best practices of pharmaceutical facility design with an emphasis on regulatory aspects. FDA and other global regulatory body requirements are discussed and the reasoning behind them
Why should you Attend:
- The attendee will learn what is important in facility design from the FDA and regulatory standpoint.
- The attendee will understand what FDA looks for during a facility inspection.
- The attendee will be able to minimize possible design errors which are difficult and expensive to fix post-build.
- The attendee will understand what FDA looks for in reviewing the facility design and the flow patterns.
Areas Covered in the Session:
- Best design practices for Pharma facilities
- Best design practices for biologics facilities
- Regulatory compliance for Pharma and biologics facilities design
- Flow patterns and cross contamination controls
Who Will Benefit:
- Compliance Manager
- Facility Manager
- Validation Manager
- Regulatory Manager
- Design Team/Architects
Speaker and Presenter Information
John R. Godshalk
Senior Consultant, Biologics Consulting Group
John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy.
Relevant Government Agencies
Pharmaceutical
Event Type
Webcast
This event has no exhibitor/sponsor opportunities
When
Tue, Apr 4, 2017, 10:00am - 11:00am
PT
Cost
General admission: | $150.00 |
Website
Click here to visit event website
Organizer
NetZealous - Compliance4All
Join the event conversation:
@Compliance4all
#Compliance4all